AbbVie Inc (ABBV) Q1 2020 earnings call dated May. 01, 2020 Corporate Participants: Liz Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of
AbbVie Inc (NYSE: ABBV) Q1 2020 Earnings Call Transcript
Categories
Biotechnology
ImmunoGen Inc. (NASDAQ: IMGN) Q1 2020 Earnings Call Transcript
ImmunoGen Inc. (IMGN) Q1 2020 earnings call dated May 01, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor Relations
Amarin Corporation plc (NASDAQ: AMRN) Q1 2020 Earnings Call Transcript
Amarin Corporation plc (AMRN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John F.
Gilead Sciences Inc. (NASDAQ: GILD) Q1 2020 Earnings Call Transcript
Gilead Sciences Inc. (GILD) Q1 2020 earnings call dated April 30, 2020 Corporate Participants: Douglas Maffei -- Investor Relations Daniel O'Day -- Chairman and Chief Executive
A visual dashboard of Amgen’s (AMGN) Q1 2020 earnings results
Amgen's (NASDAQ: AMGN) top and bottom line in the first quarter of 2020 beat analysts' estimates. The biotech firm's adjusted earnings per
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q1 2020 Earnings Call Transcript
Vertex Pharmaceuticals Inc (VRTX) Q1 2020 earnings call dated Apr. 29, 2020 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations Reshma
What to expect from Vertex Pharmaceuticals (VRTX) Q1 2020 earnings?
Biotechnology is the one industry that has been showing signs of improvement in the COVID-19 affected market. This week a bunch of
Lexicon Pharmaceuticals (NASDAQ: LXRX) Q1 2020 Earnings Call Transcript
Lexicon Pharmaceuticals (LXRX) Q1 2020 earnings call dated Apr. 27, 2020 Corporate Participants: Kimberly Lee -- Head of Investor Relations and Corporate Strategy Lonnel
Delay in filing Biogen’s Alzheimer’s drug leaves analysts scratching head during conference call
Late last year, Biogen (NASDAQ: BIIB) made an announcement that left investors gung-ho. The stock soared 27% after the company optimistically said
Eli Lilly & Co (NYSE: LLY) Q1 2020 Earnings Call Transcript
Eli Lilly & Co (LLY) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Kevin Hern -- Vice President, Investor Relations David A.
Biogen Inc (NASDAQ: BIIB) Q1 2020 Earnings Call Transcript
Biogen Inc (BIIB) Q1 2020 earnings call dated Apr. 22, 2020 Corporate Participants: Joe Mara -- Vice President, Investor Relations Michel Vounatsos -- Chief Executive Officer
Infographic: Biogen (BIIB) Q1 2020 Earnings Results
Biogen Inc. (NASDAQ: BIIB) reported its financial results for the quarter ended March 31, 2020 today. Biogen posted a 1% decline in
Amarin (AMRN) exploring use of VASCEPA in COVID-19-related cardiovascular risk reduction
Shares of Amarin Corporation plc (NASDAQ: AMRN) were up 4.6% in midday trade on Tuesday, a day after the company reported preliminary
A visual representation of Johnson & Johnson (JNJ) Q1 2020 earnings results
Johnson & Johnson (NYSE: JNJ) reported that its first-quarter 2020 earnings and revenue came in above the analysts' expectations citing product sales
Amarin Corporation plc (NASDAQ: AMRN) Q1 2020 Earnings Call Transcript
Amarin Corporation plc (AMRN) Q1 2020 earnings call dated Apr. 13, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John Thero -- President
IPOs filed in the first three months of 2020
2019 was a great year for the IPO market in which more than 200 companies went public in the US. The notable
Sanofi SA (NASDAQ: SNY) Q4 2019 Earnings Call Transcript
Sanofi SA (SNY) Q4 2019 earnings call dated Feb. 06, 2020 Corporate Participants: Felix Lauscher -- Head of Investor Relations Paul Hudson -- Chief Executive Officer
Quest Diagnostics Inc. (NYSE: DGX) Q4 2019 Earnings Call Transcript
Quest Diagnostics (DGX) Q4 2019 earnings call dated Jan. 30, 2020 Corporate Participants: Shawn Bevec -- Vice President of Investor Relations Stephen H. Rusckowski -- Chairman,
Vertex Pharmaceuticals (VRTX) stock soars to record high on bullish outlook
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to be in the luxury of escaping from the COVID-19 pandemic crisis. The stock reflected the
Illumina Inc (NASDAQ: ILMN) Q4 2019 Earnings Call Transcript
Illumina Inc (NASDAQ: ILMN) Q4 2019 Earnings Conference Call January 29, 2020 Corporate Participants: Jacquie Ross -- Investor Relations Francis deSouza -- President and Chief Executive Officer
AbbVie Inc (NYSE: ABBV) Q4 2019 Earnings Call Transcript
AbbVie Inc (NYSE: ABBV) Q4 2019 Earnings Conference Call February 07, 2020 Corporate Participants: Liz Shea -- Vice President of Investor Relations Richard A. Gonzalez -- Chairman